{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T20:55:51Z","timestamp":1781816151150,"version":"3.54.5"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computational Biology and Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.compbiolchem.2026.109062","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T17:36:21Z","timestamp":1775756181000},"page":"109062","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Mapping the structural requirements for SIRT2 inhibition: Insights from a diverse in-house library and 3D-QSAR analysis"],"prefix":"10.1016","volume":"124","author":[{"given":"Fikriye","family":"Ozgencil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokcen","family":"Eren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.compbiolchem.2026.109062_bib1","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.3390\/ph16091316","article-title":"Novel thiazole-based SIRT2 inhibitors discovered via molecular modelling studies and enzymatic assays","volume":"16","author":"Abbotto","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"7","key":"10.1016\/j.compbiolchem.2026.109062_bib2","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1021\/acs.jmedchem.5b01376","article-title":"5-((3-Amidobenzyl)oxy)nicotinamides as Sirtuin 2 inhibitors","volume":"59","author":"Ai","year":"2016","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.compbiolchem.2026.109062_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.70256","article-title":"Structure-guided optimization and biological validation of 1,3,4-thiadiazole-based SIRT2 inhibitors reinforcing channel entrance interactions","volume":"87","author":"Aksel","year":"2026","journal-title":"Drug Dev. Res."},{"issue":"10","key":"10.1016\/j.compbiolchem.2026.109062_bib4","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1080\/10406638.2025.2562259","article-title":"Targeting SIRT2 with oxadiazole\/thiadiazole-based acetamides: in silico screening and in vitro cytotoxicity evaluation","volume":"45","author":"Aksel","year":"2025","journal-title":"Polycycl. Aromat. Compd."},{"issue":"4","key":"10.1016\/j.compbiolchem.2026.109062_bib5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1248\/cpb.c24-00774","article-title":"Molecular modeling, synthesis, and preliminary cytotoxicity evaluation of new indole-based molecules as possible sirtuin inhibitors","volume":"73","author":"Ali","year":"2025","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.compbiolchem.2026.109062_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116302","article-title":"Ligand-based design and synthesis of new trityl histamine and trityl cysteamine derivatives as SIRT2 inhibitors for cancer therapy","volume":"269","author":"Badran","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.compbiolchem.2026.109062_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.110274","article-title":"Structural basis for sirtuin 2 activity and modulation: current state and opportunities","volume":"301","author":"Bernhard","year":"2025","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.compbiolchem.2026.109062_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101723","article-title":"Deglutarylation of glutaryl-CoA dehydrogenase by deacylating enzyme SIRT5 promotes lysine oxidation in mice","volume":"298","author":"Bhatt","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.compbiolchem.2026.109062_bib9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.molcel.2008.09.018","article-title":"The SIRT2 deacetylase regulates autoacetylation of p300","volume":"32","author":"Black","year":"2008","journal-title":"Mol. Cell"},{"issue":"6","key":"10.1016\/j.compbiolchem.2026.109062_bib10","doi-asserted-by":"crossref","first-page":"662","DOI":"10.2174\/1389450111314060007","article-title":"Structure and evolution of human sirtuins","volume":"14","author":"Bordo","year":"2013","journal-title":"Curr. Drug Targets"},{"issue":"15","key":"10.1016\/j.compbiolchem.2026.109062_bib11","doi-asserted-by":"crossref","first-page":"12632","DOI":"10.1074\/jbc.M111830200","article-title":"Conserved enzymatic production and biological effect of O-Acetyl-ADP-ribose by silent information regulator 2-like NAD+-dependent deacetylases","volume":"277","author":"Borra","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.compbiolchem.2026.109062_bib12","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1021\/acs.jcim.3c00556","article-title":"Discovery of novel SIRT1\/2 inhibitors with effective cytotoxicity against human leukemia cells","volume":"63","author":"Cai","year":"2023","journal-title":"J. Chem. Inf. Model."},{"issue":"6","key":"10.1016\/j.compbiolchem.2026.109062_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115353","article-title":"Unexpected small molecules as novel SIRT2 suicide inhibitors","volume":"28","author":"Chen","year":"2020","journal-title":"Bioorg. & Med. Chem."},{"issue":"3","key":"10.1016\/j.compbiolchem.2026.109062_bib14","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1039\/C4MB00620H","article-title":"Molecular modelling studies of sirtuin 2 inhibitors using three-dimensional structure\u2013activity relationship analysis and molecular dynamics simulations","volume":"11","author":"Chuang","year":"2015","journal-title":"Mol. Biosyst."},{"issue":"12","key":"10.1016\/j.compbiolchem.2026.109062_bib15","doi-asserted-by":"crossref","first-page":"10076","DOI":"10.1021\/acs.jmedchem.4c00229","article-title":"Structure\u2013activity studies of 1,2,4-oxadiazoles for the inhibition of the NAD+-dependent lysine deacylase sirtuin 2","volume":"67","author":"Colcerasa","year":"2024","journal-title":"J. Med. Chem."},{"issue":"18","key":"10.1016\/j.compbiolchem.2026.109062_bib16","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1021\/ja00226a005","article-title":"Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins","volume":"110","author":"Cramer","year":"1988","journal-title":"J. Am. Chem. Soc."},{"issue":"9","key":"10.1016\/j.compbiolchem.2026.109062_bib17","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1021\/jm400204k","article-title":"Discovery of Thieno[3,2\u2011d]pyrimidine-6-carboxamides as potent inhibitors of SIRT1, SIRT2, and SIRT3.","volume":"56","author":"Disch","year":"2013","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.compbiolchem.2026.109062_bib18","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1021\/acs.jcim.2c00241","article-title":"Expanding the accessible chemical space of SIRT2 inhibitors through exploration of binding pocket dynamics","volume":"62","author":"Djokovic","year":"2022","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.compbiolchem.2026.109062_bib19","series-title":"Comprehensive Medicinal Chemistry II","first-page":"575","article-title":"Three-Dimensional Quantitative Structure\u2013Activity Relationship: The State of the Art","author":"Doweyko","year":"2007"},{"issue":"16","key":"10.1016\/j.compbiolchem.2026.109062_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127330","article-title":"Exploring the newer oxadiazoles as real inhibitors of human SIRT2 in hepatocellular cancer cells","volume":"30","author":"Dukanya","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.compbiolchem.2026.109062_bib21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jmgm.2019.02.014","article-title":"Pharmacophore modeling and virtual screening studies to identify novel selective SIRT2 inhibitors","volume":"89","author":"Eren","year":"2019","journal-title":"J. Mol. Graph. Model."},{"issue":"2","key":"10.1016\/j.compbiolchem.2026.109062_bib22","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1080\/07391102.2019.1574603","article-title":"QSAR studies on the human sirtuin 2 inhibition by non-covalent 7,5,2-anilinobenzamide derivatives","volume":"38","author":"Ferreira","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"52","key":"10.1016\/j.compbiolchem.2026.109062_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202516782","article-title":"From pharmacophore to warhead: NAD(+)-targeting triazoles as mechanism-based sirtuin inhibitors","volume":"64","author":"Friedrich","year":"2025","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"11","key":"10.1016\/j.compbiolchem.2026.109062_bib24","doi-asserted-by":"crossref","first-page":"10771","DOI":"10.1021\/acs.jmedchem.4c02896","article-title":"Efficient crystallization of Apo Sirt2 for small-molecule soaking and structural analysis of ligand interactions","volume":"68","author":"Friedrich","year":"2025","journal-title":"J. Med. Chem."},{"issue":"5-6","key":"10.1016\/j.compbiolchem.2026.109062_bib25","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1023\/A:1020869118689","article-title":"Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection","volume":"16","author":"Golbraikh","year":"2002","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.compbiolchem.2026.109062_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105746","article-title":"Hit evaluation results in 5-benzyl-1,3,4-thiadiazole-2-carboxamide based SIRT2-selective inhibitor with improved affinity and selectivity","volume":"123","author":"Gozelle","year":"2022","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.compbiolchem.2026.109062_bib27","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1080\/07391102.2023.2293252","article-title":"silico approach reveals N-(5-phenoxythiophen-2-yl)-2-(arylthio)acetamides as promising selective SIRT2 inhibitors: the case of structural optimization of virtual screening-derived hits","volume":"43","author":"Gozelle","year":"2025","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"2","key":"10.1016\/j.compbiolchem.2026.109062_bib28","first-page":"317","article-title":"Linker and tail group modifications on 2-((4-isopropyl-4H-1,2,4-triazol-3-yl)thio)-N-(4-phenoxyphenyl)acetamide to improve SIRT2 inhibitory potency","volume":"49","author":"Gozelle","year":"2024","journal-title":"FABAD J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.compbiolchem.2026.109062_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.33435\/tcandtc.1224592","article-title":"Identification of selisistat derivatives as SIRT1-3 inhibitors by in silico virtual screening","volume":"8","author":"Hasan","year":"2024","journal-title":"Turk. Comput. Theor. Chem."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109062_bib30","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1038\/s41598-023-28226-7","article-title":"silico drug discovery of SIRT2 inhibitors from natural source as anticancer agents","volume":"13","author":"Ibrahim","year":"2023","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.compbiolchem.2026.109062_bib31","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00894-022-05288-4","article-title":"Research and study of 2-((4,6 dimethyl pyrimidine-2-yle) thio)-N-phenyl acetamide derivatives as inhibitors of sirtuin 2 protein for the treatment of cancer using QSAR, molecular docking and molecular dynamic simulation","volume":"28","author":"Ilaghi-Hoseini","year":"2022","journal-title":"J. Mol. Model"},{"key":"10.1016\/j.compbiolchem.2026.109062_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2024.108242","article-title":"Integration of 3D-QSAR, molecular docking, and machine learning techniques for rational design of nicotinamide-based SIRT2 inhibitors","volume":"113","author":"Ilic","year":"2024","journal-title":"Comput. Biol. Chem."},{"issue":"2","key":"10.1016\/j.compbiolchem.2026.109062_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics18020273","article-title":"Current computational approaches for the discovery of novel anticancer agents targeting VEGFR and SIRT signaling pathways","volume":"18","author":"Ilic","year":"2026","journal-title":"Pharmaceutics"},{"issue":"6771","key":"10.1016\/j.compbiolchem.2026.109062_bib34","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/35001622","article-title":"Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase","volume":"403","author":"Imai","year":"2000","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.compbiolchem.2026.109062_bib35","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1021\/cr500457h","article-title":"Sirtuins in epigenetic regulation","volume":"115","author":"Jing","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.compbiolchem.2026.109062_bib36","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.3390\/cells10102739","article-title":"Sirtuins as Interesting Players in the Course of HIV Infection and Comorbidities","volume":"10","author":"Jurkowska","year":"2021","journal-title":"Cells"},{"issue":"17","key":"10.1016\/j.compbiolchem.2026.109062_bib37","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1021\/acs.biochem.2c00211","article-title":"Small Changes Make the Difference for SIRT2: Two Different Binding Modes for 3-Arylmercapto-Acylated Lysine Derivatives","volume":"61","author":"Kalbas","year":"2022","journal-title":"Biochemistry"},{"issue":"9","key":"10.1016\/j.compbiolchem.2026.109062_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/cem.3171","article-title":"Estimation of predictive performance for test data in applicability domains using y-randomization","volume":"33","author":"Kaneko","year":"2019","journal-title":"J. Chemom."},{"issue":"12","key":"10.1016\/j.compbiolchem.2026.109062_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202400661","article-title":"Symmetrical 2,7-disubstituted 9H-fluoren-9-one as a novel and promising scaffold for selective targeting of SIRT2","volume":"357","author":"Kaya","year":"2024","journal-title":"Arch. der Pharm."},{"issue":"4","key":"10.1016\/j.compbiolchem.2026.109062_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.22224","article-title":"2-(Methyl(phenyl)amino)-N-(phenyloxyphenyl)acetamide structural motif representing a framework for selective SIRT2 inhibition","volume":"85","author":"Kaya","year":"2024","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.compbiolchem.2026.109062_bib41","article-title":"Selective inhibition of SIRT2: A disputable therapeutic approach in cancer therapy","volume":"143","author":"Kaya","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.compbiolchem.2026.109062_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1531246","article-title":"Emerging roles of mitochondrial sirtuin SIRT5 in succinylation modification and cancer development","volume":"16","author":"Ke","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.compbiolchem.2026.109062_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111926","article-title":"Synthesis of certain benzothieno[3,2-d]pyrimidine derivatives as a selective SIRT2 inhibitors","volume":"187","author":"Khalil","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"16","key":"10.1016\/j.compbiolchem.2026.109062_bib44","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.2174\/1871520621666210112121523","article-title":"Discovery of Potent Natural-Product-Derived SIRT2 Inhibitors Using Structure- Based Exploration of SIRT2 Pharmacophoric Space Coupled With QSAR Analyses","volume":"21","author":"Khanfar","year":"2021","journal-title":"Anti-Cancer Agents Med. Chem."},{"issue":"9","key":"10.1016\/j.compbiolchem.2026.109062_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/jmr.2623","article-title":"Unsupervised pharmacophore modeling combined with QSAR analyses revealed novel low micromolar SIRT2 inhibitors","volume":"30","author":"Khanfar","year":"2017","journal-title":"J. Mol. Recognit."},{"issue":"4","key":"10.1016\/j.compbiolchem.2026.109062_bib46","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ccr.2011.09.004","article-title":"SIRT2 Maintains Genome Integrity and Suppresses Tumorigenesis through Regulating APC\/C Activity","volume":"20","author":"Kim","year":"2011","journal-title":"Cancer Cell"},{"issue":"1-2","key":"10.1016\/j.compbiolchem.2026.109062_bib47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/10629360601053984","article-title":"The quality of QSAR models: problems and solutions","volume":"18","author":"Kolossov","year":"2007","journal-title":"SAR QSAR Environ. Res."},{"issue":"3","key":"10.1016\/j.compbiolchem.2026.109062_bib48","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s13105-016-0492-6","article-title":"The role of sirtuins in cellular homeostasis","volume":"72","author":"Kupis","year":"2016","journal-title":"J. Physiol. Biochem."},{"issue":"5","key":"10.1016\/j.compbiolchem.2026.109062_bib49","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ccr.2008.03.004","article-title":"Discovery, In Vivo Activity, and Mechanism of Action of a Small-Molecule p53 Activator","volume":"13","author":"Lain","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.compbiolchem.2026.109062_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2024.129620","article-title":"Novel xanthone derivatives as potent sirtuin 2 inhibitors","volume":"100","author":"Mazur","year":"2024","journal-title":"Bioorg. & Med. Chem. Lett."},{"key":"10.1016\/j.compbiolchem.2026.109062_bib51","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s13046-016-0461-5","article-title":"Sirtuins in metabolism, DNA repair and cancer","volume":"35","author":"Mei","year":"2016","journal-title":"J. Exp. & Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.compbiolchem.2026.109062_bib52","doi-asserted-by":"crossref","first-page":"6400","DOI":"10.1039\/C7SC02738A","article-title":"Potent mechanism-based sirtuin-2-selective inhibition by an in situ-generated occupant of the substrate-binding site, \u201cselectivity pocket\u201d and NAD+-binding site.","volume":"8","author":"Mellini","year":"2017","journal-title":"Chem. Sci."},{"issue":"12","key":"10.1016\/j.compbiolchem.2026.109062_bib53","doi-asserted-by":"crossref","first-page":"5844","DOI":"10.1021\/acs.jmedchem.9b00255","article-title":"Identification of Diketopiperazine-Containing 2-Anilinobenzamides as Potent Sirtuin 2 (SIRT2)-Selective Inhibitors Targeting the \u201cSelectivity Pocket\u201d, Substrate-Binding Site, and NAD+-Binding Site.","volume":"62","author":"Mellini","year":"2019","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109062_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20070140","article-title":"Sirtuins in mammals: insights into their biological function","volume":"404","author":"Michan","year":"2007","journal-title":"Biochem. J."},{"issue":"6","key":"10.1016\/j.compbiolchem.2026.109062_bib55","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1021\/acs.jmedchem.6b01609","article-title":"Development of 1,2,4-Oxadiazoles as Potent and Selective Inhibitors of the Human Deacetylase Sirtuin 2: Structure\u2013Activity Relationship, X-ray Crystal Structure, and Anticancer Activity","volume":"60","author":"Moniot","year":"2017","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.compbiolchem.2026.109062_bib56","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1021\/ci600224n","article-title":"3D QSAR Studies on Protein Tyrosine Phosphatase 1B Inhibitors:\u2009Comparison of the Quality and Predictivity among 3D QSAR Models Obtained from Different Conformer-Based Alignments","volume":"46","author":"Pandey","year":"2006","journal-title":"J. Chem. Inf. Model."},{"issue":"4","key":"10.1016\/j.compbiolchem.2026.109062_bib57","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1158\/1535-7163.MCT-09-0971","article-title":"SIRT Inhibitors Induce Cell Death and p53 Acetylation through Targeting Both SIRT1 and SIRT2","volume":"9","author":"Peck","year":"2010","journal-title":"Mol. Cancer Ther."},{"issue":"20","key":"10.1016\/j.compbiolchem.2026.109062_bib58","doi-asserted-by":"crossref","first-page":"11084","DOI":"10.3390\/ijms252011084","article-title":"Discovery of Novel Thiazole-Based SIRT2 Inhibitors as Anticancer Agents: Molecular Modeling, Chemical Synthesis and Biological Assays","volume":"25","author":"Piacente","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.compbiolchem.2026.109062_bib59","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.chembiol.2016.05.015","article-title":"SIRT2- and NRF2-Targeting Thiazole-Containing Compound with Therapeutic Activity in Huntington's Disease Models","volume":"23","author":"Quinti","year":"2016","journal-title":"Cell Chem. Biol."},{"issue":"11","key":"10.1016\/j.compbiolchem.2026.109062_bib60","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1038\/s41401-020-00609-w","article-title":"SL010110, a lead compound, inhibits gluconeogenesis via SIRT2-p300-mediated PEPCK1 degradation and improves glucose homeostasis in diabetic mice","volume":"42","author":"Ren","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"12","key":"10.1016\/j.compbiolchem.2026.109062_bib61","doi-asserted-by":"crossref","DOI":"10.1172\/JCI158978","article-title":"An allosteric inhibitor of sirtuin 2 deacetylase activity exhibits broad-spectrum antiviral activity","volume":"133","author":"Roche","year":"2023","journal-title":"J. Clin. Investig."},{"issue":"Pt 24","key":"10.1016\/j.compbiolchem.2026.109062_bib62","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1242\/jcs.073783","article-title":"SIRT2 regulates NF-\u03baB dependent gene expression through deacetylation of p65 Lys310","volume":"123","author":"Rothgiesser","year":"2010","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109062_bib63","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.1038\/ncomms7263","article-title":"Selective Sirt2 inhibition by ligand-induced rearrangement of the active site","volume":"6","author":"Rumpf","year":"2015","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.compbiolchem.2026.109062_bib64","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1021\/acs.jmedchem.5b01517","article-title":"Aminothiazoles as Potent and Selective Sirt2 Inhibitors: A Structure\u2013Activity Relationship Study","volume":"59","author":"Schiedel","year":"2016","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.compbiolchem.2026.109062_bib65","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cmet.2007.11.006","article-title":"Conserved Metabolic Regulatory Functions of Sirtuins","volume":"7","author":"Schwer","year":"2008","journal-title":"Cell Metab."},{"issue":"23","key":"10.1016\/j.compbiolchem.2026.109062_bib66","doi-asserted-by":"crossref","first-page":"9870","DOI":"10.1021\/jm500930h","article-title":"Chroman-4-one- and Chromone-Based Sirtuin 2 Inhibitors with Antiproliferative Properties in Cancer Cells","volume":"57","author":"Seifert","year":"2014","journal-title":"J. Med. Chem."},{"issue":"17","key":"10.1016\/j.compbiolchem.2026.109062_bib67","doi-asserted-by":"crossref","first-page":"6726","DOI":"10.7150\/thno.100667","article-title":"Targeting sirtuins for cancer therapy: epigenetics modifications and beyond","volume":"14","author":"Shen","year":"2024","journal-title":"Theranostics"},{"issue":"21","key":"10.1016\/j.compbiolchem.2026.109062_bib68","doi-asserted-by":"crossref","first-page":"14787","DOI":"10.1021\/acs.jmedchem.3c01385","article-title":"Development of First-in-Class Dual Sirt2\/HDAC6 Inhibitors as Molecular Tools for Dual Inhibition of Tubulin Deacetylation","volume":"66","author":"Sinatra","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2026.109062_bib69","first-page":"223","article-title":"Application of Structure-Based Alignment Methods for 3D QSAR Analyses, in","author":"Sippl","year":"2006","journal-title":"Pharm. Pharm. Search."},{"issue":"11","key":"10.1016\/j.compbiolchem.2026.109062_bib70","doi-asserted-by":"crossref","first-page":"14360","DOI":"10.1021\/acsomega.9b02221","article-title":"Evolving Concept of Activity Cliffs","volume":"4","author":"Stumpfe","year":"2019","journal-title":"Acs Omega"},{"issue":"10","key":"10.1016\/j.compbiolchem.2026.109062_bib71","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s00044-021-02782-x","article-title":"The potential of 4-aryl-6-morpholino-3(2H)-pyridazinone-2-arylpiperazinylacetamide as a new scaffold for SIRT2 inhibition: in silico approach guided by pharmacophore mapping and molecular docking","volume":"30","author":"Sukuroglu","year":"2021","journal-title":"Med. Chem. Res."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109062_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104589","article-title":"From obstacle to design advantage: activity cliff aware modeling for small-molecule drug discovery","volume":"31","author":"Szostek","year":"2026","journal-title":"Drug Discov. Today"},{"issue":"41","key":"10.1016\/j.compbiolchem.2026.109062_bib73","doi-asserted-by":"crossref","first-page":"25738","DOI":"10.1039\/D1RA04061H","article-title":"Structure-based design, synthesis, and biological evaluation of novel piperine\u2013resveratrol hybrids as antiproliferative agents targeting SIRT-2","volume":"11","author":"Tantawy","year":"2021","journal-title":"RSC Adv."},{"issue":"6","key":"10.1016\/j.compbiolchem.2026.109062_bib74","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1021\/cb100376q","article-title":"A brain-permeable small molecule reduces neuronal cholesterol by inhibiting activity of sirtuin 2 deacetylase","volume":"6","author":"Taylor","year":"2011","journal-title":"ACS Chem. Biol."},{"issue":"22","key":"10.1016\/j.compbiolchem.2026.109062_bib75","doi-asserted-by":"crossref","first-page":"8609","DOI":"10.3390\/ijms21228609","article-title":"A Molecular Perspective on Sirtuin Activity","volume":"21","author":"Teixeira","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109062_bib76","doi-asserted-by":"crossref","first-page":"8529","DOI":"10.1038\/srep08529","article-title":"Efficient demyristoylase activity of SIRT2 revealed by kinetic and structural studies","volume":"5","author":"Teng","year":"2015","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.compbiolchem.2026.109062_bib77","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/ci0342268","article-title":"Comparing the quality and predictiveness between 3D QSAR models obtained from manual and automated alignment","volume":"44","author":"Tervo","year":"2004","journal-title":"J. Chem. Inf. Comput. Sci."},{"issue":"25","key":"10.1016\/j.compbiolchem.2026.109062_bib78","doi-asserted-by":"crossref","first-page":"7307","DOI":"10.1021\/jm060118b","article-title":"Adenosine mimetics as inhibitors of NAD-Dependent histone deacetylases, from kinase to sirtuin inhibition","volume":"49","author":"Trapp","year":"2006","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.compbiolchem.2026.109062_bib79","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s11224-020-01714-6","article-title":"Gaussian field-based comparative 3D QSAR modelling for the identification of favourable pharmacophoric features of chromene derivatives as selective inhibitors of ALR2 over ALR1","volume":"32","author":"Verma","year":"2021","journal-title":"Struct. Chem."},{"issue":"4","key":"10.1016\/j.compbiolchem.2026.109062_bib80","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1474-9726.2007.00304.x","article-title":"SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction","volume":"6","author":"Wang","year":"2007","journal-title":"Aging Cell"},{"issue":"12","key":"10.1016\/j.compbiolchem.2026.109062_bib81","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2174\/1568026619666190510103416","article-title":"Recent progress on the discovery of sirt2 inhibitors for the treatment of various cancers","volume":"19","author":"Wang","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"issue":"11","key":"10.1016\/j.compbiolchem.2026.109062_bib82","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.1039\/D5MD00144G","article-title":"Tailored SirReal-type inhibitors enhance SIRT2 inhibition through ligand stabilization and disruption of NAD(+) co-factor binding","volume":"16","author":"Wirawan","year":"2025","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.compbiolchem.2026.109062_bib83","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1177\/026119290403201s117","article-title":"Report of the workshop on the validation of QSARs and other computational prediction models","volume":"32","author":"Worth","year":"2004","journal-title":"Altern. Lab. Anim."},{"key":"10.1016\/j.compbiolchem.2026.109062_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115961","article-title":"Hit-to-lead optimization on aryloxybenzamide derivative virtual screening hit against SIRT","volume":"30","author":"Yagci","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2026.109062_bib85","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.ejmech.2018.06.041","article-title":"X-ray crystal structure guided discovery of new selective, substrate-mimicking sirtuin 2 inhibitors that exhibit activities against non-small cell lung cancer cells","volume":"155","author":"Yang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2026.109062_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172847","article-title":"Review of the anti-inflammatory effect of SIRT1 and SIRT2 modulators on neurodegenerative diseases","volume":"867","author":"Zhang","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.compbiolchem.2026.109062_bib87","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1021\/jm301431y","article-title":"The 2.5 \u00c5 crystal structure of the SIRT1 catalytic domain bound to nicotinamide adenine dinucleotide (NAD+) and an indole (EX527 Analogue) reveals a novel mechanism of histone deacetylase inhibition","volume":"56","author":"Zhao","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2026.109062_bib88","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9282484","article-title":"Multiple roles of SIRT2 in regulating physiological and pathological signal transduction","volume":"2022","author":"Zhu","year":"2022","journal-title":"Genet. Res."},{"issue":"15","key":"10.1016\/j.compbiolchem.2026.109062_bib89","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1080\/17568919.2025.2542712","article-title":"Discovery of novel SIRT2 inhibitors with anti-NSCLC activity through multi-virtual screening and biological evaluation","volume":"17","author":"Zhu","year":"2025","journal-title":"Future Med. Chem."},{"issue":"11","key":"10.1016\/j.compbiolchem.2026.109062_bib90","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.3390\/ijms22116108","article-title":"Docking-Based 3D-QSAR Studies for 1,3,4-oxadiazol-2-one Derivatives as FAAH Inhibitors","volume":"22","author":"Zieba","year":"2021","journal-title":"Int. J. Mol. Sci."}],"container-title":["Computational Biology and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927126001878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927126001878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T20:15:07Z","timestamp":1781813707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476927126001878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":90,"alternative-id":["S1476927126001878"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2026.109062","relation":{},"ISSN":["1476-9271"],"issn-type":[{"value":"1476-9271","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mapping the structural requirements for SIRT2 inhibition: Insights from a diverse in-house library and 3D-QSAR analysis","name":"articletitle","label":"Article Title"},{"value":"Computational Biology and Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2026.109062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109062"}}